Search

Chienhung Chou

from Dublin, CA
Age ~56

Chienhung Chou Phones & Addresses

  • Dublin, CA
  • Livermore, CA
  • San Ramon, CA
  • Alameda, CA

Publications

Us Patents

Glp-1R Modulating Compounds

View page
US Patent:
20220306614, Sep 29, 2022
Filed:
Mar 9, 2022
Appl. No.:
17/690851
Inventors:
- Foster City CA, US
Chienhung Chou - Dublin CA, US
Jeromy J. Cottell - Redwood City CA, US
Chao-I Hung - San Mateo CA, US
Michael L. Mitchell - Castro Valley CA, US
Scott D. Schroeder - Union City CA, US
Nathan D. Shapiro - Belmont CA, US
Suzanne M. Szewczyk - San Mateo CA, US
James G. Taylor - Burlingame CA, US
Nathan E. Wright - San Diego CA, US
Sheila M. Zipfel - Schaumburg IL, US
International Classification:
C07D 405/14
A61K 31/4545
A61K 45/06
C07D 401/14
A61K 31/4725
C07D 413/14
C07D 417/14
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Glp-1R Modulating Compounds

View page
US Patent:
20220298148, Sep 22, 2022
Filed:
Mar 9, 2022
Appl. No.:
17/690889
Inventors:
- Foster City CA, US
Chienhung Chou - Dublin CA, US
Jeromy J. Cottell - Redwood City CA, US
Chao-I Hung - San Mateo CA, US
Michael L. Mitchell - Castro Valley CA, US
James G. Taylor - Burlingame CA, US
Nathan E. Wright - San Diego CA, US
Zheng-Yu Yang - Palo Alto CA, US
Sheila M. Zipfel - Schaumburg IL, US
International Classification:
C07D 409/14
A61P 1/16
A61K 45/06
A61K 31/4545
C07D 417/14
C07D 405/14
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Glp-1R Modulating Compounds

View page
US Patent:
20220288030, Sep 15, 2022
Filed:
Jan 27, 2021
Appl. No.:
17/159485
Inventors:
- Foster City CA, US
Gediminas J. Brizgys - San Carlos CA, US
James S. Cassidy - Foster City CA, US
Elbert Chin - San Mateo CA, US
Chienhung Chou - Dublin CA, US
Jeromy J. Cottell - Redwood City CA, US
Chao-I Hung - Foster City CA, US
Kavoos Kolahdouzan - San Francisco CA, US
Daniel G. Shore - Redwood City CA, US
Suzanne M. Szewczyk - San Mateo CA, US
James G. Taylor - Burlingame CA, US
Nathan E. Wright - Foster City CA, US
Zheng-Yu Yang - Palo Alto CA, US
International Classification:
A61K 31/4184
A61K 45/06
C07D 405/10
C07D 405/14
C07D 409/14
C07D 413/10
C07D 498/04
C07D 471/04
C07D 493/04
C07D 493/10
A61K 31/424
A61K 31/437
A61K 31/444
A61K 31/4439
A61K 31/4192
A61K 31/4196
A61K 31/422
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition.

Therapeutic Compounds

View page
US Patent:
20220267302, Aug 25, 2022
Filed:
Jan 26, 2022
Appl. No.:
17/584643
Inventors:
- Foster City CA, US
Eda Canales - San Mateo CA, US
Chienhung Chou - Dublin CA, US
Michael Graupe - Pacifica CA, US
Jiayao Li - Foster City CA, US
Roland D. Saito - San Mateo CA, US
Scott D. Schroeder - Union City CA, US
Winston C. Tse - Redwood CA, US
Qiaoyin Wu - Foster City CA, US
Jennifer R. Zhang - Union City CA, US
International Classification:
C07D 401/14
A61P 31/18
C07D 405/14
C07D 413/14
Abstract:
The invention provides compounds having Formula (I):or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising the same, processes for their preparation, and methods of treating and preventing HIV infection by their administration.

Glp-1R Modulating Compounds

View page
US Patent:
20220177449, Jun 9, 2022
Filed:
Nov 18, 2021
Appl. No.:
17/530300
Inventors:
- Foster City CA, US
James S. Cassidy - San Francisco CA, US
Chienhung Chou - Dublin CA, US
Jeromy J. Cottell - Redwood City CA, US
Chao-I Hung - San Mateo CA, US
Kavoos Kolahdouzan - San Francisco CA, US
James G. Taylor - Burlingame CA, US
Nathan E. Wright - San Diego CA, US
Zheng-Yu Yang - Palo Alto CA, US
International Classification:
C07D 401/14
C07D 405/14
A61K 45/06
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Glp-1R Modulating Compounds

View page
US Patent:
20230102927, Mar 30, 2023
Filed:
Apr 19, 2022
Appl. No.:
17/724212
Inventors:
- Foster City CA, US
James S. Cassidy - San Francisco CA, US
Elbert Chin - San Mateo CA, US
Chienhung Chou - Dublin CA, US
Jeromy J. Cottell - Redwood City CA, US
Chao-I Hung - San Mateo CA, US
Kavoos Kolahdouzan - San Francisco CA, US
David W. Lin - Berkeley CA, US
Michael L. Mitchell - Castro Valley CA, US
Ezra Roberts - San Francisco CA, US
Scott D. Schroeder - Union City CA, US
Nathan D. Shapiro - Belmont CA, US
James G. Taylor - Burlingame CA, US
Nathan E. Wright - San Diego CA, US
Zheng-Yu Yang - Palo Alto CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07D 405/14
C07D 401/14
C07D 401/10
C07D 401/08
C07D 471/04
A61K 31/4439
C07D 491/048
A61K 31/497
A61K 31/437
A61K 31/506
A61K 31/5377
C07D 409/14
C07D 493/08
C07D 493/10
C07D 417/14
C07F 9/6558
A61K 31/675
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Glp-1R Modulating Compounds

View page
US Patent:
20230021705, Jan 26, 2023
Filed:
Apr 19, 2022
Appl. No.:
17/723758
Inventors:
- Foster City CA, US
Gediminas J. Brizgys - San Carlos CA, US
James S. Cassidy - San Francisco CA, US
Elbert Chin - San Mateo CA, US
Chienhung Chou - Dublin CA, US
Chao-I Hung - San Mateo CA, US
David W. Lin - Berkeley CA, US
Michael L. Mitchell - Castro Valley CA, US
Ezra Roberts - San Francisco CA, US
Scott D. Schroeder - Union City CA, US
James G. Taylor - Burlingame CA, US
Nathan E. Wright - San Diego CA, US
Zheng-Yu Yang - Palo Alto CA, US
International Classification:
A61K 31/5383
C07D 417/14
C07D 405/14
C07D 498/04
C07D 413/14
C07D 513/04
C07D 471/04
C07D 487/04
C07D 409/14
C07D 401/14
C07D 491/08
C07D 495/04
A61K 45/06
A61K 31/423
A61K 31/137
A61K 31/357
A61K 31/135
A61K 38/22
A61K 31/5375
A61K 31/4188
A61K 35/60
A61K 31/4439
A61K 31/437
A61K 31/519
A61K 31/4985
A61K 31/444
A61K 31/4995
A61K 31/497
A61K 31/5377
A61K 31/4545
C07D 401/10
A61K 31/427
A61K 31/433
C07D 403/12
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Pyrrolo[1,2-B]Pyridazine Derivatives

View page
US Patent:
20210214363, Jul 15, 2021
Filed:
Dec 3, 2020
Appl. No.:
17/110734
Inventors:
- Foster City CA, US
Elizabeth M. Bacon - Burlingame CA, US
Gediminas Brizgys - San Carlos CA, US
Elbert Chin - San Mateo CA, US
Chienhung Chou - Dublin CA, US
Jeromy J. Cottell - Redwood City CA, US
Marilyn Ndukwe - Lebanon NH, US
James G. Taylor - Burlingame CA, US
Nathan E. Wright - Foster City CA, US
Zheng-Yu Yang - Palo Alto CA, US
Sheila M. Zipfel - San Mateo CA, US
International Classification:
C07D 487/04
Abstract:
A compound of Formula (I):pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof, wherein the variable substituents are disclosed herein.
Chienhung Chou from Dublin, CA, age ~56 Get Report